Renalytix (LSE:RENX) COGS-to-Revenue : 1.12 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Renalytix COGS-to-Revenue?

Renalytix's Cost of Goods Sold for the three months ended in Mar. 2024 was £0.47 Mil. Its Revenue for the three months ended in Mar. 2024 was £0.42 Mil.

Renalytix's COGS to Revenue for the three months ended in Mar. 2024 was 1.12.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Renalytix's Gross Margin % for the three months ended in Mar. 2024 was -12.35%.

Renalytix COGS-to-Revenue Historical Data

The historical data trend for Renalytix's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix COGS-to-Revenue Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

COGS-to-Revenue

Get a 7-Day Free Trial

0.54

0.71

0.79

Renalytix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.83	1.30	1.09	0.64	1.12

Renalytix COGS-to-Revenue Calculation

Renalytix's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2.125	/	2.695
	=	0.79

Renalytix's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.473	/	0.421
	=	1.12

Renalytix (LSE:RENX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Renalytix's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.473 / 0.421
	=	-12.35 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Renalytix COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Renalytix's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix (LSE:RENX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

RNLX:USA RTNXF:USA 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex • 12-14-2012

Investing in Information

By Vanina Egea Vanina Egea • 03-06-2014

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe • 08-29-2013

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

By PRNewswire PRNewswire • 03-27-2018